1. Home
  2. IMCR vs ENR Comparison

IMCR vs ENR Comparison

Compare IMCR & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$30.63

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$16.97

Market Cap

1.3B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCR
ENR
Founded
2008
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
IMCR
ENR
Price
$30.63
$16.97
Analyst Decision
Buy
Buy
Analyst Count
11
7
Target Price
$64.70
$25.00
AVG Volume (30 Days)
347.6K
1.2M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
7.29%
EPS Growth
30.39
538.46
EPS
N/A
3.32
Revenue
$249,428,000.00
$2,952,700,000.00
Revenue This Year
$14.39
$4.51
Revenue Next Year
$8.19
$1.07
P/E Ratio
N/A
$4.96
Revenue Growth
43.05
2.28
52 Week Low
$23.15
$16.38
52 Week High
$40.71
$30.50

Technical Indicators

Market Signals
Indicator
IMCR
ENR
Relative Strength Index (RSI) 39.51 25.48
Support Level N/A N/A
Resistance Level $34.86 $21.25
Average True Range (ATR) 1.69 0.89
MACD -0.12 -0.50
Stochastic Oscillator 10.94 8.12

Price Performance

Historical Comparison
IMCR
ENR

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About ENR Energizer Holdings Inc.

Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.

Share on Social Networks: